Regulation of the PI3-K/Akt survival pathway in the rat endometrium

Biology of Reproduction

Volumn 88, Issue 3, 2013, Pages

  Veillette, Annabelle ^a   Grenier, Kathy ^a   Brasseur, Kevin ^a   Fréchette Frigon, Guylaine ^a   Leblanc, Valérie ^a   Parent, Sophie ^a   Asselin, Eric ^a  

^a UNIVERSITÉ DU QUÉBEC À TROIS RIVIÈRES   (Canada)

Author keywords

Akt; NF B; phosphatidylinositol 3 kinase; PTEN; TGF ; XIAP

Indexed keywords

PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; SMAD2 PROTEIN; TRANSFORMING GROWTH FACTOR BETA2; X LINKED INHIBITOR OF APOPTOSIS;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; ENDOMETRIUM; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; FEMALE; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PSEUDOPREGNANCY; RAT;

ANIMALS; CARRIER PROTEINS; EMBRYO IMPLANTATION; ENDOMETRIUM; FEMALE; I-KAPPA B PROTEINS; MITOCHONDRIAL PROTEINS; PHOSPHATIDYLINOSITOL 3-KINASES; POSTPARTUM PERIOD; PREGNANCY; PREGNANCY, ANIMAL; PROTO-ONCOGENE PROTEINS C-AKT; PSEUDOPREGNANCY; PTEN PHOSPHOHYDROLASE; RATS; RATS, SPRAGUE-DAWLEY; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

RATTUS;

EID: 84877074695     PISSN: 00063363     EISSN: 15297268     Source Type: Journal    
DOI: 10.1095/biolreprod.112.107136     Document Type: Article

References (53)

1. Tabibzadeh S, Babaknia A. Molecular aspects of implantation: The signals and molecular pathways involved in implantation, a symbiotic interaction between blastocyst and endometrium involving adhesion and tissue invasion. Hum Reprod 1995; 10:1579.1602.
2. Parr EL, Tung H, Parr MB. Apoptosis as the mode of uterine epithelial cell death during embryo implantation in mice and rats. Biol Reprod 1987; 36:211.225.
3. Pampfer S, Donnay I. Apoptosis at the time of embryo implantation in mouse and rat. Cell Death Differ 1999; 6:533.
4. Moulton B. Transforming growth factor-beta stimulates endometrial stromal apoptosis in vitro. Endocrinology 1994; 134:1055.
5. Shooner C, Caron PL, Fréchette-Frigon G, Leblanc V, Déry MC, Asselin E. TGF-beta expression during rat pregnancy and activity on decidual cell survival. Reprod Biol Endocrinol 2005; 3:20.22.
6. del Re E, Babitt JL, Pirani A, Schneyer AL, Lin HY. In the absence of type III receptor, the transforming growth factor (TGF)-β type II-B receptor requires the type I receptor to bind TGF-b2. J Biol Chem 2004; 279:22765.22772.
7. Qian SW, Dumont N, O'Connor-McCourt MD, Burmester JK. distinct functional domains of TGF-β bind receptors on endothelial cells. Growth Factors 1999; 17:63.73.
8. Attisano L, Wrana JL. Signal transduction by the TGF-β superfamily. Science 2002; 296:1646.
9. Itoh S, Itoh F, Goumans M-J, ten Dijke P. Signaling of transforming growth factor-β family members through Smad proteins. Eur J Biochem 2000; 267:6954.6967.
10. Yoshida K, Matsuzaki K, Mori S, Tahashi Y, Yamagata H, Furukawa F, Seki T, Nishizawa M, Fujisawa J, Okazaki K. Transforming growth factorb and platelet-derived growth factor signal via c-Jun N-terminal kinasedependent Smad2/3 phosphorylation in rat hepatic stellate cells after acute liver injury. Am J Pathol 2005; 166:1029.1039.
11. Caron PL, Fréchette-Frigon G, Shooner C, Leblanc V, Asselin E. Transforming growth factor beta isoforms regulation of Akt activity and XIAP levels in rat endometrium during estrous cycle, in a model of pseudopregnancy and in cultured decidual cells. Reprod Biol Endocrinol 2009; 7:80.
12. Vanhaesebroeck B, Alessi DR. The PI3K-PDK1 connection: more than just a road to PKB. Biochem J 2000; 346:561.576.
13. Dan HC, Sun M, Kaneko S, Feldman RI, Nicosia SV, Wang H-G, Tsang BK, Cheng JQ. Akt phosphorylation and stabilization of X-linked inhibitor of apoptosis protein (XIAP). J Biol Chem 2004; 279:5405.5412.
14. Goswami A, Burikhanov R, de Thonel A, Fujita N, Goswami M, Zhao Y, Eriksson JE, Tsuruo T, Rangnekar VM. Binding and phosphorylation of Par-4 by Akt is essential for cancer cell survival. Mol Cell 2005; 20:33.44.
15. Adams JM, Cory S. The Bcl-2 protein family: arbiters of cell survival. Science 1998; 281:1322.
16. Yang L, Sun M, Sun X-m, Cheng GZ, Nicosia SV, Cheng JQ. Akt attenuation of the serine protease activity of HtrA2/Omi through phosphorylation of serine 212. J Biol Chem 2007; 282:10981.10987.
17. Wang Y, Chang J, Li Y-C, Li Y-S, Shyy JY-J, Chien S. Shear stress and VEGF activate IKK via the Flk-1/Cbl/Akt signaling pathway. Am J Physiol Heart Circ Physiol 2004; 286:H685.H692.
18. Ackerman WE, Zhang XL, Rovin BH, Kniss DA. Modulation of cytokineinduced cyclooxygenase 2 expression by PPARG ligands through NFjB signal disruption in human WISH and amnion cells. Biol Reprod 2005; 73:527.535.
19. Honda Y, Tanikawa H, Fukuda J, Kawamura K, Sato N, Sato T, Shimizu Y, Kodama H, Tanaka T. Expression of Smac/DIABLO in mouse preimplantation embryos and its correlation to apoptosis and fragmentation. Mol Hum Reprod 2004; 11:183.
20. Leblanc V, Dery MC, Shooner C, Asselin E. Opposite regulation of XIAP and Smac/DIABLO in the rat endometrium in response to 17beta-estradiol at estrus. Reprod Biol Endocrinol 2003; 1:59.
21. Asselin E, Wang Y, Tsang BK. X-Linked inhibitor of apoptosis protein activates the phosphatidylinositol 3-kinase/Akt pathway in rat granulosa cells during follicular development. Endocrinology 2001; 142:2451.2457.
22. Asselin E, Mills GB, Tsang BK. XIAP regulates Akt activity and caspase-3-dependent cleavage during cisplatin-induced apoptosis in human ovarian epithelial cancer cells. Cancer Res 2001; 61:1862.1868.
23. Van Themsche C, Leblanc V, Parent S, Asselin E. X-linked inhibitor of apoptosis protein (XIAP) regulates PTEN ubiquitination, content, and compartmentalization. J Biol Chem 2009; 284:20462.20466.
24. Singh VP, Saluja AK, Bhagat L, van Acker GJD, Song AM, Soltoff SP, Cantley LC, Steer ML. Phosphatidylinositol 3-kinase-dependent activation of trypsinogen modulates the severity of acute pancreatitis. J Clin Invest 2001; 108:1387.1395.
25. Vlahos CJ, Matter WF, Hui KY, Brown RF. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem 1994; 269:5241.5248.
26. Chen WS, Xu P-Z, Gottlob K, Chen M-L, Sokol K, Shiyanova T, Roninson I, Weng W, Suzuki R, Tobe K, Kadowaki T, Hay N. Growth retardation and increased apoptosis in mice with homozygous disruption of the akt1 gene. Genes Dev 2001; 15:2203.2208.
27. Cho H, Thorvaldsen JL, Chu Q, Feng F, Birnbaum MJ. Akt1/PKBa is required for normal growth but dispensable for maintenance of glucose homeostasis in mice. J Biol Chem 2001; 276:38349.38352.
28. Garofalo RS, Orena SJ, Rafidi K, Torchia AJ, Stock JL, Hildebrandt AL, Coskran T, Black SC, Brees DJ, Wicks JR, McNeish JD, Coleman KG. Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2/PKBb. J Clin Invest 2003; 112:197.208.
29. Tschopp O, Yang Z-Z, Brodbeck D, Dummler BA, Hemmings-Mieszczak M, Watanabe T, Michaelis T, Frahm J, Hemmings BA. Essential role of protein kinase Bc (PKBc/Akt3) in postnatal brain development but not in glucose homeostasis. Development 2005; 132:2943.2954.
30. Peng X-d, Xu P-Z, Chen M-L, Hahn-Windgassen A, Skeen J, Jacobs J, Sundararajan D, Chen WS, Crawford SE, Coleman KG, Hay N. Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2. Genes Dev 2003; 17:1352.1365.
31. Yang Z-Z, Tschopp O, Di-Poï N, Bruder E, Baudry A, Dümmler B, Wahli W, Hemmings BA. Dosage-dependent effects of Akt1/protein kinase Ba (PKBα) and Akt3/PKBc on thymus, skin, and cardiovascular and nervous system development in mice. Mol Cell Biol 2005; 25:10407.10418.
32. Dummler B, Tschopp O, Hynx D, Yang Z-Z, Dirnhofer S, Hemmings BA. Life with a single isoform of Akt: mice lacking Akt2 and Akt3 are viable but display impaired glucose homeostasis and growth deficiencies. Mol Cell Biol 2006; 26:8042.8051.
33. Gonzalez E, McGraw TE. The Akt kinases: isoform specificity in metabolism and cancer. Cell Cycle 2009; 8:2502.2508.
34. Dery MC, Leblanc V, Shooner C, Asselin E. Regulation of Akt expression and phosphorylation by 17b-estradiol in the rat uterus during estrous cycle. Reprod Biol Endocrinol 2003; 1:47.
35. Du C, Fang M, Li Y, Li L, Smac, Wang X. Smac, a mitochondrial protein that promotes cytochrome c. dependent caspase activation by eliminating IAP inhibition. Cell 2000; 102:33.42.
36. Reffey SB, Wurthner JU, Parks WT, Roberts AB, Duckett CS. X-linked inhibitor of apoptosis protein functions as a cofactor in transforming growth factor-β signaling. J Biol Chem 2001; 276:26542.26549.
37. Van Themsche C, Chaudhry P, Leblanc V, Parent S, Asselin E. XIAP gene expression and function is regulated by autocrine and paracrine TGFbeta signaling. Mol Cancer 2010; 9:216.
38. Béraud C, Henzel WJ, Baeuerle PA. Involvement of regulatory and catalytic subunits of phosphoinositide 3-kinase in N-κB activation. Proc Natl Acad Sci U S A 1999; 96:429.
39. St-Germain ME, Gagnon V, Parent S, Asselin E. Regulation of COX-2 protein expression by Akt in endometrial cancer cells is mediated through NF-κ/IκB pathway. Mol Cancer 2004; 3:7.
40. Gagnon V, St-Germain ME, Parent S, Asselin E. Akt activity in endometrial cancer cells: regulation of cell survival through cIAP-1. Int J Oncol 2003; 23:803.
41. King AE, Critchley HOD, Kelly RW. The NF-κB pathway in human endometrium and first trimester decidua. Mol Hum Reprod 2001; 7:175.183.
42. Kelly RW. Pregnancy maintenance and parturition: the role of prostaglandin in manipulating the immune and inflammatory response. Endocr Rev 1994; 15:684.706.
43. Wissink S, van Heerde EC, van der Burg B, van der Saag PT. A dual mechanism mediates repression of NF-κB activity by glucocorticoids. Mol Endocrinol 1998; 12:355.363.
44. St-Louis I, Singh M, Brasseur K, Leblanc V, Parent S, Asselin E. Expression of COX-1 and COX-2 in the endometrium of cyclic, pregnant and in a model of pseudopregnant rats and their regulation by sex steroids. Reprod Biol Endocrinol 2010; 8:103.
45. Stambolic V, Tsao MS, Macpherson D, Suzuki A, Chapman WB, Mak TW. High incidence of breast and endometrial neoplasia resembling human Cowden syndrome in pten+/- mice. Cancer Res 2000; 60:3605.
46. Maehama T, Dixon JE. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3, 4, 5-trisphosphate. J Biol Chem 1998; 273:13375.
47. Mutter GL, Lin MC, Fitzgerald JT, Kum JB, Eng C. Changes in endometrial PTEN expression throughout the human menstrual cycle. J Clin Endocrinol Metab 2000; 85:2334.
48. Yang YFS, Jensen JP, Weissman AM, Ashwell JD. Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in responses to apoptotic stimuli. Science 2000; 288:874.877
49. Kayisli UA, Guzeloglu-Kayisli O, Arici A. Endocrine-immune interactions in human endometrium. Ann NY Acad Sci 2004; 1034:50-63.
50. Alarcón C, Zaromytidou A-I, Xi Q, Gao S, Yu J, Fujisawa S, Barlas A, Miller AN, Manova-Todorova K, Macias MJ, Sapkota G, Pan D, et al. Nuclear CDKs drive Smad transcriptional activation and turnover in BMP and TGF-β pathways. Cell 2009; 139:757-769.
51. Remy I, Montmarquette A, Michnick SW. PKB/Akt modulates TGF-[beta] signalling through a direct interaction with Smad3. Nat Cell Biol 2004; 6:358-365.
52. Liu Y, Shreder KR, Gai W, Corral S, Ferris DK, Rosenblum JS. Wortmannin, a widely used phosphoinositide 3-kinase inhibitor, also potently inhibits mammalian Polo-like kinase. Chem Biol 2005; 12:99-107.
53. Bazer FW, Spencer TE, Johnson GA, Burghardt RC, Wu G. Comparative aspects of implantation. Reproduction 2009; 138:195-209.